Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran

INTRODUCTION: Dabigatran etexilate was the first direct-acting oral anticoagulant approved in the United States. The prevalence of intracranial hemorrhage after blunt head trauma in patients on dabigatran is currently unknown, complicating adequate ability to accurately compare the risks and benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenoweth, James A., Johnson, M. Austin, Shook, Laura, Sutter, Mark E., Nishijima, Daniel K., Holmes, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2017
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576614/
https://www.ncbi.nlm.nih.gov/pubmed/28874930
http://dx.doi.org/10.5811/westjem.2017.5.33092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576614/
https://www.ncbi.nlm.nih.gov/pubmed/28874930
http://dx.doi.org/10.5811/westjem.2017.5.33092

Ejemplares similares